Cargando…

Identification of CD4(+) T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system of autoimmune etiopathogenesis, and is characterized by various neurological symptoms. Glatiramer acetate and interferon-β are administered as first-line treatments for this disease. In non-responsive patients, s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fagone, Paolo, Mazzon, Emanuela, Mammana, Santa, Di Marco, Roberto, Spinasanta, Flaminia, Basile, Maria Sofia, Petralia, Maria Cristina, Bramanti, Placido, Nicoletti, Ferdinando, Mangano, Katia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580020/ https://www.ncbi.nlm.nih.gov/pubmed/31180553 http://dx.doi.org/10.3892/mmr.2019.10283

Ejemplares similares

The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
por: Mammana, Santa, et al.
Publicado: (2018)

Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis
por: Mammana, Santa, et al.
Publicado: (2018)

Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach
por: Mangano, Katia, et al.
Publicado: (2018)

Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma
por: Cavalli, Eugenio, et al.
Publicado: (2019)

Upregulated Expression of Macrophage Migration Inhibitory Factor, Its Analogue D-Dopachrome Tautomerase, and the CD44 Receptor in Peripheral CD4 T Cells from Clinically Isolated Syndrome Patients with Rapid Conversion to Clinical Defined Multiple Sclerosis
por: Cavalli, Eugenio, et al.
Publicado: (2019)

Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy
por: Lombardo, Salvo Danilo, et al.
Publicado: (2019)

Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis
por: Lombardo, Salvo Danilo, et al.
Publicado: (2019)

Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression
por: Petralia, Maria Cristina, et al.
Publicado: (2019)

Comparison of efficacy and safety of oral agents for the treatment of relapsing–remitting multiple sclerosis
por: Guarnera, Cristina, et al.
Publicado: (2017)

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
por: Guarnera, Cristina, et al.
Publicado: (2017)

Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma
por: Presti, Mario, et al.
Publicado: (2018)

Impaired Expression of Tetraspanin 32 (TSPAN32) in Memory T Cells of Patients with Multiple Sclerosis
por: Basile, Maria Sofia, et al.
Publicado: (2020)

The neuropathic pain: An overview of the current treatment and future therapeutic approaches
por: Cavalli, Eugenio, et al.
Publicado: (2019)

Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine
por: Lombardo, Salvo Danilo, et al.
Publicado: (2019)

Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
por: Cavalli, Eugenio, et al.
Publicado: (2020)

Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling
por: Lombardo, Salvo Danilo, et al.
Publicado: (2019)

The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy
por: Giacoppo, Sabrina, et al.
Publicado: (2017)

Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders
por: Petralia, Maria Cristina, et al.
Publicado: (2020)

In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod
por: Cavalli, Eugenio, et al.
Publicado: (2019)

Transcriptomic Data Analysis Reveals a Down-Expression of Galectin-8 in Schizophrenia Hippocampus
por: Petralia, Maria Cristina, et al.
Publicado: (2021)

The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Effects of Treatment with the Hypomethylating Agent 5-aza-2′-deoxycytidine in Murine Type II Collagen-Induced Arthritis
por: Petralia, Maria Cristina, et al.
Publicado: (2019)

A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy
por: Lombardo, Salvo Danilo, et al.
Publicado: (2021)

Natalizumab: A new treatment for relapsing remitting multiple sclerosis
por: Hutchinson, Michael
Publicado: (2007)

Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis
por: Nakamura, Masataka, et al.
Publicado: (2017)

The H(2)S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide
por: Lazarević, Milica, et al.
Publicado: (2018)

A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients
por: Gugliandolo, Agnese, et al.
Publicado: (2018)

Transcriptomic analysis of COVID-19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection
por: Cavalli, Eugenio, et al.
Publicado: (2020)

Profiling of inhibitory immune checkpoints in glioblastoma: Potential pathogenetic players
por: Lombardo, Salvo Danilo, et al.
Publicado: (2020)

Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait
por: Alroughani, R., et al.
Publicado: (2013)

A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis
por: Trojano, Maria, et al.
Publicado: (2021)

Meta-Analysis of Transcriptomic Data of Dorsolateral Prefrontal Cortex and of Peripheral Blood Mononuclear Cells Identifies Altered Pathways in Schizophrenia
por: Petralia, Maria Cristina, et al.
Publicado: (2020)

Effects of Combined Admistration of Imatinib and Sorafenib in a Murine Model of Liver Fibrosis
por: Pesce, Antonio, et al.
Publicado: (2020)

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
por: Silvestro, Serena, et al.
Publicado: (2019)

Differential modulation and prognostic values of immune-escape genes in uveal melanoma
por: Basile, Maria Sofia, et al.
Publicado: (2019)

The Dichotomic Role of Macrophage Migration Inhibitory Factor in Neurodegeneration
por: Basile, Maria Sofia, et al.
Publicado: (2020)

Cognitive Decline in Rheumatoid Arthritis: Insight into the Molecular Pathogenetic Mechanisms
por: Basile, Maria Sofia, et al.
Publicado: (2021)

Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
por: Petralia, Maria Cristina, et al.
Publicado: (2019)

KCNMA1 Expression Is Downregulated in Colorectal Cancer via Epigenetic Mechanisms
por: Basile, Maria Sofia, et al.
Publicado: (2019)

Treatment with Natalizumab in Relapsing–Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory Mechanism
por: Ramos-Cejudo, Jaime, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2ud54f0lsdv6s75lh3i53bdg0t